Global Proteomics Market (2020 to 2025) – by Application, Indication, Technology, Type, Product, End-user, & Region – ResearchAndMarkets.com

November 12, 2020 Off By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Global Proteomics Market By Application (Drug Discovery, Diagnostic Biomarker Discovery, Others), By Indication (Infectious Disease, Cardiology, Others), By Technology, By Type, By Product, By End-User, By Region, Competition, Forecast & Opportunities, 2025” report has been added to ResearchAndMarkets.com’s offering.

The Global Proteomics Market is expected to grow at a brisk CAGR during the forecast period. The key factor responsible for increased demand for proteomics is due to growing investments in research and development activities in end-use industries such as the biotechnology sector and the pharmaceutical industry.

Additionally, increasing demand for personalized medicine is anticipated to bode well for the growth of proteomics market across the globe in the coming years. Moreover, increasing government support in terms of providing funds is anticipated to bolster the market growth through 2025.

The Global Proteomics Market is segmented based on application, indication, technology, type, product, end-user, region and company. Based on application, the market can be segmented into drug discovery, diagnostic biomarker discovery, clinical diagnostic, others. Out of which, the clinical diagnostics segment dominated the market in terms of largest market size until 2019 and is further anticipated to maintain its leading position during the forecast period as well. This growth can be accredited to enhanced knowledge of understanding the patterns of protein expression for disease diagnostics and development of drug. Also, tandem MS and LC are some proteomics technology that are effective for the identification of proteins, thus boosting the growth of the segment across the globe.

Objective of the Study:

  • To analyse and forecast the market size of the Global Proteomics Market.
  • To classify and forecast the Global Proteomics Market based on application, indication, technology, type, product, end-user, company and regional distribution.
  • (Read more…)

  • To identify drivers and challenges for the Global Proteomics Market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in the Global Proteomics Market.
  • To conduct pricing analysis for the Global Proteomics Market.
  • To identify and analyse the profile of leading players operating in the Global Proteomics Market.

Companies Mentioned

  • Thermo Fisher Scientific
  • Agilent Technologies
  • Waters Corporation
  • Bio-Rad Laboratories
  • GE Healthcare
  • PerkinElmer
  • Creative Proteomics
  • Luminex Corporation
  • Promega Corporation
  • Caprion
  • Bruker
  • Pfizer
  • Horiba
  • Qiagen
  • Becton Dickinson
  • Bioproximity
  • Biocon
  • Evotec
  • Bristol-Myers Squibb
  • Illumina
  • Takeda Pharmaceuticals

Key Topics Covered:

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Global Proteomics Market Outlook

4.1. Market Size & Forecast

4.1.1. By Value & Volume

4.2. Market Share & Forecast

4.2.1. By Application (Drug Discovery, Diagnostic Biomarker Discovery, Clinical diagnostic, Others)

4.2.2. By Indication (Infectious Disease, Cardiology, Neurovascular, Diabetes, Others)

4.2.3. By Technology

4.2.3.1.1. Conventional (Chromatography (HPLC, Affinity, Others), ELISA, Western blotting)

4.2.3.1.2. Advanced (Protein microarray (Analytical, Functional, Reverse-phase), Gel electrophoresis (2D, Capillary, SDS-PAGE, 2D-DIGE), Mass Spectrophotometry, Edman Sequencing)

4.2.3.1.3. Quantitative (Isotope-coded affinity tag (ICAT) labeling, Stable isotope labeling with amino acids in cell culture (SILAC), Isobaric tag for relative and absolute quantitation (iTRAQ))

4.2.3.1.4. High-thoroughput (X-ray crystallography, NMR)

4.2.3.1.5. Bioinformatic analysis

4.2.4. By Type (Functional, Expression, Structural, Computational)

4.2.5. By Product (Software, Instruments, Reagents and Assays, Services)

4.2.6. By End-User (Pharmaceutical and biotechnology companies, Research institutes, CROs)

4.2.7. By Company (2019)

4.2.8. By Region

4.3. Market Attractiveness Index

5. Asia-Pacific Proteomics Market Outlook

5.1. Market Size & Forecast

5.2. Market Share & Forecast

5.3. Market Attractiveness Index

5.4. Asia-Pacific: Country Analysis

6. Europe Proteomics Market Outlook

6.1. Market Size & Forecast

6.2. Market Share & Forecast

6.3. Market Attractiveness Index

6.4. Europe: Country Analysis

7. North America Proteomics Market Outlook

7.1. Market Size & Forecast

7.2. Market Share & Forecast

7.3. Market Attractiveness Index

7.4. North America: Country Analysis

8. South America Proteomics Market Outlook

8.1. Market Size & Forecast

8.2. Market Share & Forecast

8.3. Market Attractiveness Index

8.4. South America: Country Analysis

9. Middle East and Africa Proteomics Market Outlook

9.1. Market Size & Forecast

9.2. Market Share & Forecast

9.3. Market Attractiveness Index

9.4. MEA: Country Analysis

10. Market Dynamics

10.1. Drivers

10.2. Challenges

11. Market Trends & Developments

12. Competitive Landscape

12.1. Competition Outlook

12.2. Players Profiled (Leading Companies)

13. Strategic Recommendations

14. About Us & Disclaimer

For more information about this report visit https://www.researchandmarkets.com/r/62a33t

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900